Jeevan Scientific Technology

Hyderabad, India Founded: 1999 • Age: 27 yrs Listed
Healthcare outsourcing services are provided by Jeevan Scientific Technology.

About Jeevan Scientific Technology

Jeevan Scientific Technology is a publicly listed company based in Hyderabad (India) founded in 1999. Healthcare outsourcing services are provided by Jeevan Scientific Technology. The company has 263 employees. Its chief executive, as recorded, is Rajendra Prasad Muppavarapu. Its Indian entity Jeevan Scientific Technology Limited reported revenue of ₹62.51 Cr. Jeevan Scientific Technology offers products and services including BA/BE Studies, Clinical Trial Services, and Pharmacovigilance Services. Its focus areas include BPO Services, Industry Specific and Healthcare.

Company details

Jeevan Scientific Technology was founded in 1999 and is headquartered in Hyderabad, India. Outsourcing services in the healthcare sector are delivered, including support for clinical and operational needs. The company operates from its Indian base, serving clients in pharmaceuticals and related fields. Leadership is held by CEO Rajendra Prasad Muppavarapu, with a focus on established processes in the domain.

  • Headquarters Hyderabad, India
  • Employees 263
  • Stage Public
  • Sectors
    Business Services
  • Email
    ••••••••
  • Website jeevanscientific.com
  • Social LinkedIn X Facebook
  • Legal Name Jeevan Scientific Technology Ltd
Key Metrics
  • Market Cap
    ₹173 Cr

    JSTL · BSE

  • Share Price
    ₹87.00

    +1.16% today

  • Revenue
    ₹61.54 Cr

    FY 2025-26 · +31.4% YoY

  • EBITDA
    ₹9.80 Cr

    Margin 15.9%

  • Net Profit
    ₹1.15 Cr

    FY 2025-26 · +618.8% YoY

  • P/E (TTM)
    25.3x

    P/B 2.4x

  • Employee Count
    263

Products & Services of Jeevan Scientific Technology

Jeevan Scientific Technology offers a comprehensive portfolio of products and services, including BA/BE Studies, Clinical Trial Services, and Pharmacovigilance Services.

BA/BE Studies
Clinical Research

Conducts bioequivalence studies for various therapeutic areas.

Clinical Trial Services
Clinical Research

Manages trials from Phase II to IV for drugs and devices.

Pharmacovigilance Services
Safety Monitoring

Provides monitoring and reporting for drug safety compliance.

Board of directors of Jeevan Scientific Technology Limited (Jeevan Scientific Technology)

Jeevan Scientific Technology Limited is the primary company behind Jeevan Scientific Technology. The boards of the 2 registered companies of Jeevan Scientific Technology currently have 9 directors; the longest-serving is Krishna Kishore Kuchipudi, appointed in 2020. 26 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Krishna Kishore Kuchipudi
DIN 00876539
Designated Partner10 Aug 20206 yrs 3 moJstl Pharma Llp, Jeevan Scientific Technology Limited
Kuchipudi Vanaja
DIN 01030437
Designated Partner10 Aug 20206 yrs 3 moJstl Pharma Llp
Jeevan Krishna Kuchipudi
DIN 08207809
Director02 Nov 20206 yrsJeevan Scientific Technology Limited
Snigdha Mothukuri
DIN 08934860
Whole-time director02 Nov 20206 yrsJeevan Scientific Technology Limited
Nageswar Rao Yarllagadda
DIN 00293474
Whole-time director23 Jun 20215 yrs 4 moJeevan Scientific Technology Limited
Venkata Subba Rao Guttikonda
DIN 01900749
Director25 Mar 20224 yrs 7 moJeevan Scientific Technology Limited
Suryaprakasa Rao Bommisetti
DIN 08089189
Director25 Mar 20224 yrs 7 moJeevan Scientific Technology Limited
Divakar Atluri
DIN 00033386
Director14 Aug 20233 yrs 3 moJeevan Scientific Technology Limited
Gollapinwi Mallikarjuna
DIN 11189083
Director14 Aug 20251 yr 3 moJeevan Scientific Technology Limited

People of Jeevan Scientific Technology

1 people are tracked at Jeevan Scientific Technology (1 in leadership); the tracked headcount is 263.

NameRoleGroup
Rajendra Prasad Muppavarapu
CEOLeadership
Premium access

Complete people profiles for Jeevan Scientific Technology

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Jeevan Scientific Technology

Jeevan Scientific Technology is a publicly listed company on the BSE with ticker symbol JSTL in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date19 Dec 2014
  • Listed onBSE: 538837
  • Listed entityJeevan Scientific Technology Ltd
  • Exchange sectorHealth services
  • ISININE237B01018
  • Share price₹87.36 (+4.11% on the day) · 2026-10-14
  • Market capitalisation₹168 Cr
  • Price to earnings42.9
  • EPS (diluted, trailing year)₹2.03
  • Volume (last session)50,025

Financials of Jeevan Scientific Technology

Exchange-reported figures of Jeevan Scientific Technology Limited, the listed company behind Jeevan Scientific Technology (BSE: JSTL).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹61.54 Cr
+31.4% YoY
EBITDA
₹9.80 Cr
+31.0% YoY
Profit After Tax
₹1.15 Cr
+618.8% YoY
Net Worth
-
Total Assets
-
Total Debt
-

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue61.5446.8439.6536.1867.7946.9523.94
Revenue growth+31.4%+18.1%+9.6%-46.6%+44.4%+96.1%-
EBITDA9.807.484.631.3516.7517.48(6.12)
EBITDA margin+15.9%+16.0%+11.7%+3.7%+24.7%+37.2%-25.6%
Profit before tax2.090.06(1.61)(3.69)18.0213.64(10.55)
Net profit1.150.16(1.30)(3.06)9.2611.73(8.56)
Net profit margin+1.9%+0.3%-3.3%-8.5%+13.7%+25.0%-35.8%
EPS (₹)0.610.08(0.84)(1.97)7.817.67(5.61)
Balance sheet
Total assets-71.2162.4558.8363.4045.6941.43
Net worth-49.9448.4348.1950.5835.0223.22
Total debt-20.5813.4110.1012.5510.3417.95
Cash & bank-0.240.546.8329.716.212.20
Net working capital-21.6719.2622.0939.9113.595.63
Cash flow
Cash from operations-10.072.89(6.41)19.564.95(0.01)
Cash from investing-(15.62)(11.53)(6.93)(1.20)(0.80)(1.90)
Cash from financing-5.242.35(9.54)5.67(0.13)0.44
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue23.1718.2821.2919.0712.388.8010.0612.51
Revenue growth (YoY)+87.2%+107.7%+111.6%+52.4%+8.6%-31.7%--
Other income0.440.170.290.140.200.330.150.23
EBITDA5.712.954.295.232.07(1.78)(0.38)2.08
EBITDA margin+24.6%+16.1%+20.2%+27.4%+16.7%-20.2%-3.8%+16.6%
Depreciation1.801.701.611.601.691.741.771.48
Interest0.480.440.410.540.550.540.550.43
Profit before tax3.870.982.563.230.03(3.73)(2.55)0.40
Tax0.970.110.730.830.02(0.51)(1.29)0.35
Net profit2.900.871.832.400.01(3.22)(1.26)0.05
EPS (₹)1.440.431.091.520.01(2.03)(0.79)0.03
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue53.9343.6138.5036.1856.5540.4720.57
Revenue growth+23.7%+13.3%+6.4%-36.0%+39.7%+96.7%-
EBITDA8.486.534.381.3517.0616.63(5.82)
EBITDA margin+15.7%+15.0%+11.4%+3.7%+30.2%+41.1%-28.3%
Profit before tax2.640.77(1.23)(3.62)18.3313.17(9.78)
Net profit1.650.73(1.05)(3.01)9.5411.25(7.79)
Net profit margin+3.1%+1.7%-2.7%-8.3%+16.9%+27.8%-37.9%
EPS (₹)0.980.46(0.68)(1.94)8.017.36(5.11)
Balance sheet
Total assets-64.3555.0257.4663.4046.9143.14
Net worth-50.9148.8048.3250.5836.2524.93
Total debt-12.885.808.8412.5510.3417.95
Cash & bank-0.210.516.1229.715.681.88
Net working capital-23.6419.3421.6539.9114.096.93
Cash flow
Cash from operations-2.962.74(6.29)19.564.73(1.19)
Cash from investing-(9.84)(4.69)(7.27)(1.20)(0.80)(1.02)
Cash from financing-6.58(3.66)(10.03)5.67(0.13)0.44
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue20.8716.9318.3816.9110.438.228.9211.87
Revenue growth (YoY)+100.1%+106.0%+106.1%+42.5%+1.3%-34.4%--
Other income0.560.260.370.180.260.380.140.22
Total expenses15.8013.2914.9012.268.969.339.839.83
EBITDA5.073.643.484.651.47(1.11)(0.91)2.04
EBITDA margin+24.3%+21.5%+18.9%+27.5%+14.1%-13.5%-10.2%+17.2%
Depreciation1.521.431.361.351.451.501.531.23
Interest0.350.300.250.380.380.360.350.26
Profit before tax3.762.172.243.10(0.10)(2.59)(2.65)0.77
Tax1.010.300.640.80(0.01)(0.43)(1.31)0.44

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 19 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue23.1718.2821.2919.0712.388.8010.0612.51
Revenue growth (YoY)+87.2%+107.7%+111.6%+52.4%+8.6%-31.7%--
Other income0.440.170.290.140.200.330.150.23
EBITDA5.712.954.295.232.07(1.78)(0.38)2.08
EBITDA margin+24.6%+16.1%+20.2%+27.4%+16.7%-20.2%-3.8%+16.6%
Depreciation1.801.701.611.601.691.741.771.48
Interest0.480.440.410.540.550.540.550.43
Profit before tax3.870.982.563.230.03(3.73)(2.55)0.40
Tax0.970.110.730.830.02(0.51)(1.29)0.35
Net profit2.900.871.832.400.01(3.22)(1.26)0.05
EPS (₹)1.440.431.091.520.01(2.03)(0.79)0.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue61.5446.8439.6536.1867.7946.9523.94
Revenue growth+31.4%+18.1%+9.6%-46.6%+44.4%+96.1%-
Other income0.970.650.671.075.922.392.53
Total expenses51.7439.3635.0234.8351.0429.4730.06
Employee cost0.0014.9013.2812.6218.1711.059.26
EBITDA9.807.484.631.3516.7517.48(6.12)
EBITDA margin+15.9%+16.0%+11.7%+3.7%+24.7%+37.2%-25.6%
Depreciation6.646.255.935.073.693.973.92
Interest2.041.820.981.040.962.263.04
Profit before tax2.090.06(1.61)(3.69)18.0213.64(10.55)
Tax1.06(0.01)(0.28)(0.61)6.091.91(1.96)
Net profit1.150.16(1.30)(3.06)9.2611.73(8.56)
Net profit margin+1.9%+0.3%-3.3%-8.5%+13.7%+25.0%-35.8%
EPS (₹)0.610.08(0.84)(1.97)7.817.67(5.61)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital-15.8315.4815.4815.3015.3015.30
Reserves & surplus-34.1132.9532.7135.2819.727.92
Shareholders' funds (net worth)-49.9448.4348.1950.5835.0223.22
Minority interest-0.130.200.230.000.000.00
Secured loans-14.309.715.154.2310.2910.58
Unsecured loans-6.283.704.958.320.057.37
Total debt-20.5813.4110.1012.5510.3417.95
Total liabilities-71.2162.4558.8363.4045.6941.43
Assets
Gross block-74.7460.2152.3340.8545.3944.75
Net block-34.5426.6724.9819.0727.3730.54
Capital work in progress-4.712.811.900.000.000.00
Investments-0.000.000.000.000.000.00
Inventories-1.621.090.871.463.460.95
Sundry debtors-15.9412.2911.687.6114.456.84
Cash & bank balances-0.240.546.8329.716.212.20
Loans & advances-10.9510.759.8015.119.768.09
Total current assets-28.7524.6729.1853.8933.8818.08
Total current liabilities-7.085.417.0913.9820.2912.45
Net working capital-21.6719.2622.0939.9113.595.63
Total assets-71.2162.4558.8363.4045.6941.43
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash-0.546.8329.715.682.203.67
Net cash from operating activities-10.072.89(6.41)19.564.95(0.01)
Net cash from investing activities-(15.62)(11.53)(6.93)(1.20)(0.80)(1.90)
Net cash from financing activities-5.242.35(9.54)5.67(0.13)0.44
Net change in cash-(0.30)(6.29)(22.88)24.034.02(1.47)
Closing cash-0.240.546.8329.716.212.20
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+31.4%+18.1%+9.6%-46.6%+44.4%+96.1%-
EBITDA growth+31.0%+61.6%+243.0%-91.9%-4.2%+385.6%-
PBT growth+3383.3%+9998.0%+56.4%-+32.1%+9998.0%-
Net income growth+618.8%+112.3%+57.5%-133.1%-21.1%+237.0%-
Revenue CAGR (3Y)+19.4%-11.6%-5.5%+14.8%+37.4%+32.0%+9.6%
EBITDA CAGR (3Y)+93.6%-23.6%-35.8%-+42.0%+72.1%-
Profitability & leverage
Net income margin+1.7%+0.2%-3.4%-8.5%+17.6%+25.0%-35.9%
Return on capital employed-+2.8%-1.0%-4.3%+27.4%+36.5%0.0%
Return on net worth-+0.1%-2.8%-6.2%+21.7%+40.3%0.0%
Debt / equity-0.350.240.230.270.490.66
Long-term debt / equity-0.260.160.100.140.270.28
Interest cover64.56147.97-75.38-27.967.3516.73-30.28
Efficiency & per share
Fixed asset turnover-0.690.700.781.571.040.55
Inventory turnover-34.5740.4631.0627.5621.2940.58
Debtors turnover-3.323.313.756.154.412.22
EPS (₹)0.610.08(0.84)(1.97)7.817.67(5.61)
Dividend per share (₹)0.000.000.000.001.200.500.00
Book value per share (₹)0.0031.5431.2831.1333.0622.8915.18
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue20.8716.9318.3816.9110.438.228.9211.87
Revenue growth (YoY)+100.1%+106.0%+106.1%+42.5%+1.3%-34.4%--
Other income0.560.260.370.180.260.380.140.22
Total expenses15.8013.2914.9012.268.969.339.839.83
EBITDA5.073.643.484.651.47(1.11)(0.91)2.04
EBITDA margin+24.3%+21.5%+18.9%+27.5%+14.1%-13.5%-10.2%+17.2%
Depreciation1.521.431.361.351.451.501.531.23
Interest0.350.300.250.380.380.360.350.26
Profit before tax3.762.172.243.10(0.10)(2.59)(2.65)0.77
Tax1.010.300.640.80(0.01)(0.43)(1.31)0.44
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue53.9343.6138.5036.1856.5540.4720.57
Revenue growth+23.7%+13.3%+6.4%-36.0%+39.7%+96.7%-
Other income1.190.630.691.065.912.382.52
Total expenses45.4537.0834.1234.8339.4923.8426.39
Employee cost0.0013.6212.9312.6213.168.007.13
EBITDA8.486.534.381.3517.0616.63(5.82)
EBITDA margin+15.7%+15.0%+11.4%+3.7%+30.2%+41.1%-28.3%
Depreciation5.655.295.555.023.683.963.91
Interest1.381.100.751.010.961.882.57
Profit before tax2.640.77(1.23)(3.62)18.3313.17(9.78)
Tax0.990.03(0.18)(0.61)6.091.92(1.96)
Net profit1.650.73(1.05)(3.01)9.5411.25(7.79)
Net profit margin+3.1%+1.7%-2.7%-8.3%+16.9%+27.8%-37.9%
EPS (₹)0.980.46(0.68)(1.94)8.017.36(5.11)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital-15.8315.4815.4815.3015.3015.30
Reserves & surplus-35.0833.3232.8435.2820.959.63
Shareholders' funds (net worth)-50.9148.8048.3250.5836.2524.93
Secured loans-7.683.434.854.2310.2910.58
Unsecured loans-5.202.373.998.320.057.37
Total debt-12.885.808.8412.5510.3417.95
Total liabilities-64.3555.0257.4663.4046.9143.14
Assets
Gross block-67.5253.3151.3340.8538.5137.71
Net block-28.7220.2024.0319.0720.5323.68
Capital work in progress-0.000.000.000.000.000.00
Investments-2.002.002.000.001.031.03
Inventories-0.931.010.871.464.940.95
Sundry debtors-14.3911.9311.687.6112.466.00
Cash & bank balances-0.210.516.1229.715.681.88
Loans & advances-14.3810.789.2715.117.877.85
Total current assets-29.9124.2327.9453.8930.9516.68
Total current liabilities-6.274.896.2913.9816.869.75
Net working capital-23.6419.3421.6539.9114.096.93
Total assets-64.3555.0257.4663.4046.9143.14
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash-0.516.1229.715.681.883.66
Net cash from operating activities-2.962.74(6.29)19.564.73(1.19)
Net cash from investing activities-(9.84)(4.69)(7.27)(1.20)(0.80)(1.02)
Net cash from financing activities-6.58(3.66)(10.03)5.67(0.13)0.44
Net change in cash-(0.30)(5.61)(23.59)24.033.80(1.77)
Closing cash-0.210.516.1229.715.681.88
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+23.7%+13.3%+6.4%-36.0%+39.7%+96.7%-
EBITDA growth+29.9%+49.1%+224.4%-92.1%+2.6%+385.7%-
PBT growth+242.9%+9998.0%+66.0%-+39.2%+9998.0%-
Net income growth+126.0%+169.5%+65.1%-131.6%-15.2%+244.4%-
Revenue CAGR (3Y)+14.2%-8.3%-1.7%+20.7%+30.5%+28.1%+5.6%
EBITDA CAGR (3Y)+84.5%-27.4%-35.9%-+43.1%+71.1%-
Profitability & leverage
Net income margin+3.1%+1.7%-2.7%-8.3%+21.6%+27.8%-38.0%
Return on capital employed-+3.1%-0.9%-4.3%+27.7%+33.4%0.0%
Return on net worth-+1.5%-2.2%-6.1%+22.0%+36.8%0.0%
Debt / equity-0.190.150.220.260.460.63
Long-term debt / equity-0.120.070.090.140.260.27
Interest cover48.7688.71-64.10-27.527.1714.84-26.41
Efficiency & per share
Fixed asset turnover-0.720.740.781.431.060.55
Inventory turnover-44.9640.9631.0617.6713.7434.86
Debtors turnover-3.313.263.755.644.382.01
EPS (₹)0.980.46(0.68)(1.94)8.017.36(5.11)
Dividend per share (₹)0.000.000.000.001.200.500.00
Book value per share (₹)0.0032.1631.5331.2133.0623.6916.29

Web traffic of Jeevan Scientific Technology

The website of Jeevan Scientific Technology (jeevanscientific.com) receives about 1.8K visits a month.

  • Monthly visits
    1.8K

    ▲ 50% vs previous month

Top companies in Business Process Outsourcing (BPO)

3 companies that operate in the same segment as Jeevan Scientific Technology (Business Process Outsourcing (BPO)) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of outsourcing and business services
2007Bengaluru, Karnataka, IndiaUSD 1.63 B299
Cloud-based text analytics and cognitive automation services are provided.
1975Mumbai, Maharashtra, IndiaUSD 3 MUSD 217.77 M5,560
Electricity generation and distribution are provided in eastern India.
1879Kolkata, West Bengal, IndiaUSD 2.03 B5,688
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Jeevan Scientific Technology

Premium access

Complete news archive for Jeevan Scientific Technology

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jeevan Scientific Technology

Jeevan Scientific Technology was founded in 1999.

Jeevan Scientific Technology is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Rajendra Prasad Muppavarapu is the CEO of Jeevan Scientific Technology, as recorded in our data.

Jeevan Scientific Technology has 263 employees.

The primary company behind Jeevan Scientific Technology, Jeevan Scientific Technology Limited, reported revenue of ₹62.51 Cr for FY 2026, up 31% year on year.

Jeevan Scientific Technology was founded in 1999 and is headquartered in Hyderabad, India. Outsourcing services in the healthcare sector are delivered, including support for clinical and operational needs. The company operates from its Indian base, serving clients in pharmaceuticals and related fields. Leadership is held by CEO Rajendra Prasad Muppavarapu, with a focus on established processes in the domain.

Jeevan Scientific Technology offers BA/BE Studies, Clinical Trial Services, and Pharmacovigilance Services.

Yes, Jeevan Scientific Technology is publicly traded on BSE under the ticker symbol JSTL.

Jeevan Scientific Technology is associated with 2 legal entities: Jeevan Scientific Technology Limited, Jstl Pharma Llp.

The legal entities of Jeevan Scientific Technology currently have 12 directors, including Krishna Kishore Kuchipudi, Kuchipudi Vanaja, Jeevan Krishna Kuchipudi and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available